Star Health Insurance reported stronger-than-expected Q1 2026 earnings, driving shares higher in afternoon trading. The insurer posted net profit growth that outpaced analyst consensus estimates, bolstered by improved claims management and higher premium collections across its retail and group health segments.
The company's combined ratio improved to 97.2 percent in the quarter, down from 98.1 percent year-over-year, signaling better underwriting discipline. Chief Executive Officer Anand Roy attributed the performance to disciplined pricing and operational efficiencies implemented across distribution channels. "Our focus on sustainable profitability over volume growth is delivering results," Roy stated during the earnings call.
Premium income grew 12.3 percent year-over-year to Rs 1,847 crore, driven primarily by retail health insurance and group products. Claims incidence remained stable despite inflationary pressures on medical costs. The insurer maintained its solvency ratio well above regulatory minimums at 1.8x, providing flexibility for capital deployment.
Star Health's gross written premiums expanded across all major segments. Retail health insurance, the company's largest revenue driver, grew 14.2 percent. Group insurance premiums climbed 9.8 percent as corporate clients increased coverage. Management guided for mid-teen percentage premium growth in FY2027, contingent on sustained economic activity.
The stock climbed 3.4 percent to Rs 687 on the NSE following the announcement. Analysts raised price targets following the results. Morgan Stanley lifted its rating to "overweight" with a 12-month target of Rs 780, citing Star Health's improving underwriting metrics and market share gains in high-margin retail segments.
The insurer faces ongoing headwinds from medical inflation and competitive pricing pressure in the health insurance market. Consolidation rumors persist in the sector, though